Short communication · 30 Jan 2025
Research articlePublished 2013
Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: The standard of care in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) is chemotherapy and radiation; however, Radiation-Induced Lung Injury (RILI), which may be prevented by the anti-inflammatory and anti-oxidant properties of Flaxseed (FS), impedes its maximum benefit. Materials and Methods: Patients with LA-NSCLC requiring definitive RT were randomized to one FS or control muffin daily from start to 2 weeks after RT. Blood and urine were collected to quantify plasma FS metabolites, Enterodione (ED) and Enterolactone (EL), and urinary oxidative stress biomarkers, 8, 12-iso-iPF2a-VI (isoprostane) and 8-oxo-7,8-dihydro-2’deoxyguanosine (8-oxo-dGuo). Tolerability was defined as consuming ≥ 75% of the intended muffins and no ≥ grade 3 gastrointestinal toxicities. Results: Fourteen patients (control,7; FS,7) were enrolled. The tolerability rates were 42.9 versus 71.4% (p=0.59) for FS and control, respectively. Mean percentages of intended number of muffins consumed were 37% versus 73% (p=0.12). ED and EL increased at onset of FS and decreased with discontinuation, confirming bioavailability. Isoprostane and 8-oxo-dGuo were detectable. There was a trend towards decreased rates of pneumonitis in FS. Conclusions: This is the first study to report FS bioavailability and quantify oxidative stress markers in NSCLC patients. FS in the administered muffin formulation did not meet tolerability criteria. Given the promising mechanism of FS as a radioprotectant, further investigations should focus on the optimal method for administration of FS.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 31 Dec 2024
Targeting Non-small Cell Lung Cancer with Inhaled Medications
Mini review · 28 Sep 2023
Advancements in the Diagnosis and Treatment of Non-small Cell Lung Cancer
Mini review · 29 Jun 2023
Children and Adolescents in the United States with Non-Small Cell Lung Cancer: Trends and Characteristics
Mini review · 25 May 2023
Role of immunotherapy in non-small cell lung cancer
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Article · 9 Feb 2026
Magnitude and Associated Factors of Respiratory Distress Syndrome among Preterm Neonate Admitted to Addis Ababa Public Hospital, Ethiopia 2023/24
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Berman Abigail T”
- BylineArticles whose byline prints “Turowski Jason”
- BylineArticles whose byline prints “Mick Rosemarie”
- BylineArticles whose byline prints “Cengel Keith”
- BylineArticles whose byline prints “Farnese Nicole”
- BylineArticles whose byline prints “Basel-Brown Lisa”
- BylineArticles whose byline prints “Mesaros Clementina”
- BylineArticles whose byline prints “Blair Ian”

